Compumedics Ltd - Asset Resilience Ratio

Latest as of June 2022: 16.97%

Compumedics Ltd (CMP) has an Asset Resilience Ratio of 16.97% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check CMP capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$7.08 Million
≈ $5.01 Million USD Cash + Short-term Investments

Total Assets

AU$41.71 Million
≈ $29.51 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2022)

This chart shows how Compumedics Ltd's Asset Resilience Ratio has changed over time. See Compumedics Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Compumedics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Compumedics Ltd (CMP) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$7.08 Million 16.97%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$7.08 Million 16.97%

Asset Resilience Insights

  • Good Liquidity Position: Compumedics Ltd maintains a healthy 16.97% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Compumedics Ltd Industry Peers by Asset Resilience Ratio

Compare Compumedics Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Inspire Medical Systems Inc
NYSE:INSP
Medical Devices 20.29%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Stratec SE
XETRA:SBS
Medical Devices 0.30%
Duearity AB
ST:DEAR
Medical Devices 145.62%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Compumedics Ltd (2016–2022)

The table below shows the annual Asset Resilience Ratio data for Compumedics Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-06-30 16.97% AU$7.08 Million
≈ $5.01 Million
AU$41.71 Million
≈ $29.51 Million
+5.08pp
2019-06-30 11.90% AU$4.60 Million
≈ $3.25 Million
AU$38.66 Million
≈ $27.36 Million
+0.62pp
2018-06-30 11.27% AU$3.91 Million
≈ $2.76 Million
AU$34.65 Million
≈ $24.52 Million
-2.76pp
2017-06-30 14.03% AU$4.10 Million
≈ $2.90 Million
AU$29.23 Million
≈ $20.68 Million
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$26.12 Million
≈ $18.48 Million
--
pp = percentage points

About Compumedics Ltd

AU:CMP Australia Medical Devices
Market Cap
$35.62 Million
AU$50.34 Million AUD
Market Cap Rank
#23190 Global
#871 in Australia
Share Price
AU$0.25
Change (1 day)
-6.67%
52-Week Range
AU$0.24 - AU$0.45
All Time High
AU$0.90
About

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more